"Anemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Descriptor ID |
D000740
|
| MeSH Number(s) |
C15.378.071
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anemia".
Below are MeSH descriptors whose meaning is more specific than "Anemia".
This graph shows the total number of publications written about "Anemia" by people in this website by year, and whether "Anemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 4 | 0 | 4 |
| 2001 | 2 | 2 | 4 |
| 2002 | 7 | 1 | 8 |
| 2003 | 3 | 6 | 9 |
| 2004 | 5 | 0 | 5 |
| 2005 | 3 | 3 | 6 |
| 2006 | 4 | 2 | 6 |
| 2007 | 9 | 1 | 10 |
| 2008 | 6 | 2 | 8 |
| 2009 | 5 | 4 | 9 |
| 2010 | 8 | 1 | 9 |
| 2011 | 7 | 5 | 12 |
| 2012 | 4 | 0 | 4 |
| 2013 | 6 | 2 | 8 |
| 2014 | 6 | 5 | 11 |
| 2015 | 3 | 4 | 7 |
| 2016 | 9 | 4 | 13 |
| 2017 | 6 | 7 | 13 |
| 2018 | 5 | 2 | 7 |
| 2019 | 7 | 0 | 7 |
| 2020 | 6 | 2 | 8 |
| 2021 | 11 | 1 | 12 |
| 2022 | 22 | 0 | 22 |
| 2023 | 13 | 0 | 13 |
| 2024 | 3 | 1 | 4 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia" by people in Profiles.
-
Successful Treatment of Double-Positive Rapidly Progressive Glomerulonephritis: A Case Report. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251365418.
-
Investigational drugs in early phase trials for myelofibrosis. Expert Opin Investig Drugs. 2024 Dec; 33(12):1231-1244.
-
The Association Between Perioperative Red Blood Cell Transfusions and 1-Year Mortality After Major Cancer Surgery: An International Multicenter Observational Study. Anesth Analg. 2025 Apr 01; 140(4):782-794.
-
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis. Blood. 2024 10 24; 144(17):1813-1820.
-
Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care. J Palliat Med. 2024 Dec; 27(12):1639-1647.
-
Safety and efficacy of luspatercept for the treatment of anemia in?patients with myelofibrosis. Blood Adv. 2024 09 10; 8(17):4511-4522.
-
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study. Haematologica. 2024 08 01; 109(8):2660-2664.
-
Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM. Future Oncol. 2024; 20(30):2259-2270.
-
Anemia, Iron Deficiency, and Cause-Specific Mortality: The Atherosclerosis Risk in Communities Study. Gerontology. 2024; 70(10):1023-1032.
-
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 2024 Sep; 11(9):e646-e658.